BioCentury
ARTICLE | Company News

EC approves first-line use of Bristol-Myers' Yervoy

November 9, 2013 1:54 AM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) said the European Commission approved an application to expand the label of Yervoy ipilimumab to include previously untreated patients with unresectable or metastat...